USPTO Biotech/Chemical Partnership (BCP) Meetings

In This Section

Biotech/Chem/Pharma (BCP) Customer Partnership Meeting - March 28, 2023

Apr 21, 2023, 13:43 PM by AIPLA Admin
BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders. The partnership works to improve the quality of the agency’s products and services.

March 28, 2023,

10:00 a.m. – 5:00 p.m. ET

Clara Barton Auditorium and webinar
United States Patent and Trademark Office

BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders. The partnership works to improve the quality of the agency’s products and services. 

Link to the presentations in the title of each session.

10:00 – 10:10 a.m. Welcome and opening remarks

  • Robin Evans, Deputy Commissioner for Patents
  • Gladys Corcoran, Assistant Commissioner, USPTO

10:10 – 11:10 a.m. Non-Statutory Double Patenting

  • Daniel Kolker, Supervisory Patent Examiner (SPE)
  • Lora Driscoll, Technology Center Quality Assurance Specialist (TQAS) TC 1600

11:20-12:10 p.m. Non-Statutory Double Patenting

  • Daniel Kolker, Supervisory Patent Examiner (SPE)
  • Lora Driscoll, Technology Center Quality Assurance Specialist (TQAS) TC 1600
  • Gregory Emch, Supervisory Patent Examiner (SPE) 

1:45-2:30 p.m.  Patent Term Extension (PTE) under 35 U.S.C. 156

  • Andrea Grossman, Legal Advisor Office of Patent Legal Administration (OPLA)

2:30-3:30 p.m. Artificial intelligence in biotech/drug development

  • Michael Fuller, Managing Partner, Knobbe Martens

3:40-4:10 p.m.  Cancer Moonshot Expedited Examination Pilot Program

  • Gary Nickol, Supervisory Patent Examiner (SPE)
  • Brandon Fetterolf, Supervisory Patent Examiner (SPE)

4:10-4:50 p.m.  Common Mistakes ST.26

  • Christopher Babic,  Director (acting) TC 1600, USPTO
  • Mary Till, Senior Legal Advisor, Office of Patent Legal Administration (OPLA)

4:50-5:00 p.m.  Closing remarks

  • Daniel Sullivan,  Director, TC1600, USPTO
  • Gary Jones,  Director TC 1600, USPTO
  • Christopher Babic,  Director (acting) TC 1600, USPTO